Pharmagen, Inc. (PHRX)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 3, 2026

Pharmagen Company Description

Pharmagen, Inc. distributes specialty drugs to hospitals, acute care facilities, surgery centers, and other healthcare practitioners in the United States.

The company sources and distributes specialty drugs, blood plasma derivatives, specialty products, vaccines, anti-infectives, and hard-to-find pharmaceuticals.

It offers plasma derivatives for treating serious medical conditions, such as cancer, hemophilia, rheumatoid arthritis, multiple scleroses, blood disorders, hepatitis, and HIV; and specialty products for treating respiratory, oncology, cardiovascular, and hormonal syndromes.

The company also manufactures and distributes health supplements, including Clotamin, a specialized over-the-counter multivitamin dietary supplement for patients on Warfarin.

In addition, it sells traditional pharmaceuticals to its distribution customers, such as antibiotics, vaccines, and other oral and injectable pharmaceuticals; and specializes in the formulation of drugs.

The company was formerly known as Sunpeaks Ventures, Inc. and changed its name to Pharmagen, Inc. in January 2013.

Pharmagen, Inc. is based in Silver Spring, Maryland.

Pharmagen, Inc.
Country United States
Industry Medical Distribution
Sector Healthcare
Employees 24

Contact Details

Address:
9337 Fraser Avenue
Silver Spring, Maryland 20910
United States
Phone 204-898-8160

Stock Details

Ticker Symbol PHRX
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US71715W1062
SIC Code 5122

Key Executives

Name Position
Mackie A. Barch Founder and Vice Chairman